Proton pump inhibitors-induced psychiatric symptoms

被引:1
|
作者
Zhao, Li [1 ]
Xie, Dajiang [2 ]
机构
[1] Zhejiang Chinese Med Univ, Hangzhou Red Cross Hosp Integrated Tradit Chinese, Dept Gastroenterol, Hangzhou, Peoples R China
[2] Zhejiang Univ, Sir Run Run Shaw Hosp, Coll Med Sci, Dept Neurosurg, Hangzhou 310016, Peoples R China
关键词
Proton pump inhibitors; psychiatric symptoms; treatment; DELIRIUM; RABEPRAZOLE; THERAPY; RISK;
D O I
10.1080/13554794.2022.2138451
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Proton pump inhibitors are widely used in cure of digestive tract diseases and drug-induced psychiatric symptoms are rare. In this study, we aim to investigate the presentations, diagnostic approaches, treatments and prognosis. We present one case of proton pump inhibitors-induced motor hallucination underwent drug withdrawal and recovery subsequently. Delirium Rating Scale and Hamilton Anxiety Scale examinations showed transient delirium and anxiety. Proton pump inhibitors-induced psychiatric symptoms are benign and affect patients' prognosis. No standard treatment exists, and the strategies contain discontinuing proton pump inhibitors and/or antipsychotics drugs. Overall prognosis is usually good and recurrence seems to be rare.
引用
收藏
页码:415 / 418
页数:4
相关论文
共 50 条
  • [1] Mechanisms involved in proton pump inhibitors-induced increases in ischemic events
    Sertorio, Jonas T.
    Tanus-Santos, Jose E.
    ATHEROSCLEROSIS, 2019, 280 : 197 - 198
  • [2] Agranulocytosis Induced by Proton Pump Inhibitors
    Dury, Sandra
    Nardi, Julie
    Gozalo, Claire
    Lebargy, Francois
    Deslee, Gaetan
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2012, 46 (10) : 859 - 859
  • [3] Inappropriate use of proton pump inhibitors
    Molloy, D.
    Molloy, A.
    O'Loughlin, C.
    Falconer, M.
    Hennessy, M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2010, 179 (01) : 73 - 75
  • [4] Proton Pump Inhibitors in the Management of GERD
    Katz, Philip O.
    Zavala, Stacey
    JOURNAL OF GASTROINTESTINAL SURGERY, 2010, 14 : 62 - 66
  • [5] Proton pump inhibitors - are they truly safe?
    Jankowska, Agnieszka
    Landowski, Piotr
    Liberek, Anna
    Kaminska, Barbara
    PRZEGLAD GASTROENTEROLOGICZNY, 2012, 7 (03): : 133 - 137
  • [6] Bowel symptoms in patients that receive proton pump inhibitors. Results of a multicenter survey in Mexico
    Schmulson, M. J.
    Frati-Munari, A. C.
    REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2019, 84 (01): : 44 - 51
  • [7] Checkpoint inhibitors-induced hypophysitis
    du Payrat, Juliette Abeillon
    Cugnet-Anceau, Christine
    Maillet, Denis
    Levy, Manon
    Raverot, Gerald
    Disse, Emmanuel
    Borson-Chazot, Francoise
    BULLETIN DU CANCER, 2020, 107 (04) : 490 - 498
  • [8] Overuse of proton pump inhibitors and its consequences
    Kazberuk, Marcin
    Brzosko, Szymon
    Hryszko, Tomasz
    Naumnik, Beata
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2016, 70 : 1112 - 1116
  • [9] Proton pump inhibitors and cancers: A hazardous association?
    Raoul, Jean-Luc
    Edeline, Julien
    Gilabert, Marine
    Senellart, Helene
    Frenel, Jean-Sebastien
    BULLETIN DU CANCER, 2020, 107 (04) : 458 - 464
  • [10] Meta-analysis of the efficacy of proton pump inhibitors for the symptoms of laryngopharyngeal reflux
    Liu, C.
    Wang, H.
    Liu, K.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2016, 49 (07)